A research conducted by scientists at the Indian Institute of Science and Tata Institute of Fundamental Research found that administering anti-malarial drug Chloroquine with anti-TB drugs can reduce the tolerance of TB bacteria towards it. That, in turn, can help fight drug-resistant TB. In their work, the researchers noted that one of the things that make fighting TB so difficult is that the bacteria are able to increase the acidity in the area where they reside. So the researchers gave patients chloroquine to reduce acidity, along with another drug to sneak in and take out the TB bacteria. The researchers report that their idea worked in both mice and guinea pigs, reducing treatment time to just eight weeks.
Industry supervisors envisage Japan to be the second fastest growing mature marketplace for solid dose drugs in 2019 followed by the United States. The findings represent a considerable year-on-year improvement in outlook for pharma in Japan with expected growth of solid dose formulations improving by more than 10% with generic drug classes highlighted Significantly, it […]
Sci-Hub, which is repeatedly referred to as the “Pirate Bay of Science” has been providing unlawful free access to millions of paywalled scientific papers. The American Chemical Society (ACS), a leading source of academic publications in the field of chemistry, has won a lawsuit which it had filed in June against this website with regards […]
Gorgias Press and De Gruyter have come together to form a editorial and commercial agreement for Gorgias Press titles. This agreement will entitle eBook versions of all Gorgias Press titles to be available on degruyter.com. The contract includes the Gorgias Press output of 75 titles per year and a backlist of more than 3,000 titles, […]